Sepsis Prognosis Biomarker Data from a 375-Patient Retrospective Cohort Study

A retrospective cohort study of 375 sepsis patients investigates the combined prognostic value of procalcitonin (PCT) and interleukin-6 (IL-6). The dataset includes biomarker levels, Sequential Organ Failure Assessment (SOFA) scores, and outcomes like septic shock and 28-day mortality. Authored by Xuefang Xia and last updated on figshare in June 2026.

Use Cases

• Predicting sepsis severity based on combined PCT and IL-6 biomarker levels.
• Modeling the risk of septic shock using PCT levels collected within 24 hours of admission.
• Analyzing the correlation between biomarker dynamics (ΔPCT/ΔIL-6) and patient outcomes during the first week of therapy.
• Comparing the predictive performance of combined biomarker assessment against single biomarkers for early risk stratification.

Strengths

• Includes data from 375 patients, providing a substantive cohort for analysis.
• Contains longitudinal biomarker data with measurements taken over days 1-7 of therapy.
• Links biomarker levels to validated clinical scores (SOFA) and hard outcomes (septic shock, 28-day mortality).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect temporal and institutional bias inherent to a single retrospective study.

Provenance

Source

figshare

Collection Method

Retrospective cohort study of hospital patients.

Freshness

Last updated 2026-06-03 05:31:06; freshness should be verified.